In vivo CRISPR/LbCas12a-mediated knock-in and knock-out in Atlantic salmon (Salmo salar L.)

• Published in: Transgenic Research
• Main Authors: Raudstein, Mari, Kjærner-Semb, Erik, Barvik, Morten, Broll, Silje, Straume, Anne Hege, Edvardsen, Rolf Brudvik
• Format: Text
• Language: English
• Published: Springer International Publishing 2023
• Subjects: Research; Atlantic salmon; Salmo salar
• Online Access: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713776/; http://www.ncbi.nlm.nih.gov/pubmed/37733197; https://doi.org/10.1007/s11248-023-00368-4

Genome editing using the CRISPR/Cas system offers the potential to enhance current breeding programs and introduce desirable genetic traits, including disease resistance, in salmon aquaculture. Several nucleases are available using this system, displaying differences regarding structure, cleavage, and PAM requirement. Cas9 is well established in Atlantic salmon, but Cas12a has yet to be tested in vivo in this species. In the present work, we microinjected salmon embryos with LbCas12a ribonucleoprotein complexes targeting the pigmentation gene solute carrier family 45 member 2 (slc45a2). Using CRISPR/LbCas12a, we were able to knock-out slc45a2 and knock-in a FLAG sequence element by providing single-stranded DNA templates. High-throughput sequencing revealed perfect HDR rates up to 34.3% and 54.9% in individual larvae using either target or non-target strand template design, respectively. In this work, we demonstrate the in vivo application of CRISPR/LbCas12a in Atlantic salmon, expanding the toolbox for editing the genome of this important aquaculture species. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11248-023-00368-4.